Pts with advanced NSCLC who had prior CPIs treatment and a PD-L1 tumor proportion score ≥1%;AZD2936 mono; PD-L1 TPS=1-49%, 750mg, N=31; PD-L1 TPS≥50%, 750mg, N=34; PD-L1 TPS≥50%, 1500mg, N=30;. The gene discussed is CD274; the disease is neoplasm.